The location of the epitope recognized by monoclonal antibody (MAb) 63G on the primary structure of the human respiratory syncytial virus G glycoprotein was determined by testing the reactivity of synthetic peptides with the MAb. The role of individual amino acids in this epitope was determined by using a set of 13-mer peptides containing sigle residue deletions. Residues 204 to 209 were found to be essential for antibody binding. These results are in full agreement with previous sequence data for escape mutants selected with MAb 63G. Several peptides, free or bound to keyhole limpet haemocyanin (KLH), were used to raise antisera in rabbits. The antipeptide antibodies reacted with the G protein in Western blots. However, only peptide G1-KLH (residues 187 to 200 bound to KLH) induced antibodies that reacted with the intact G protein and inhibited infectivity. These findings are discussed in terms of the antigenic structure of the G glycoprotein and the molecular engineering of peptide antigens.
Introduction
The two major surface glycoproteins (G and F) of human respiratory syncytial virus (RSV) play important roles during the initial stages of the infectious cycle. The G glycoprotein is responsible for virus attachment to the cell receptor (Levine et al., 1987) and the F glycoprotein for the fusion of the viral and cell membranes (Walsh et al., 1985) , allowing the internalization of the viral ribonucleoprotein into the cell cytoplasm. Both glycoproteins contain neutralizing epitopes (Anderson et al., 1988; Beeler & van Wyke Coelingh, 1989; GarciaBarreno et al., 1989) and can induce a protective immune response in experimental animals (Walsh et al., 1987; Olmsted et al., 1986; Stott et al., 1987) .
The G glycoprotein is synthesized as a 32K precursor which is modified by the addition of N-and O-linked oligosaccharides to produce the mature form of 80K to 90K (Wertz et al., 1989) . The G protein is the viral product showing the greatest antigenic (Johnson et al., 1987; Garcia-Barreno et al., 1989) and genetic (Johnson et al., 1987; Sullender et al., 1990) variation between the A and B RSV subgroups. In addition, the G protein also shows extensive antigenic (Anderson et al., 1985; Akerlind et al., 1988; Garcia-Barreno et al., 1989) and genetic (Cane et al., 1991 ; Sullender et al., 1991) diversity among viruses of the same antigenic subgroup. The analysis of escape mutants selected with anti-G protein monoclonal antibodies (MAbs) indicates that antigenic variants of the G protein may be generated by one of three mechanisms: (i) point mutations, (ii) premature stop codons (Rueda et al., 1991) or (iii) frameshift mutations (Garcia-Barreno et al., 1990) .
The characterization of G protein epitopes may be an important step toward understanding the basis of the immune response to RSV, and to the design and evaluation of vaccines. We have previously reported the isolation and characterization of a panel of 19 MAbs directed against the G glycoprotein of RSV Long strain (Garcia-Barreno et al., 1989) . One of these (63G) has the interesting property that escape mutants selected with it contain insertions or deletions of adenosine residues which introduce drastic sequence changes in the Cterminal third of the G protein molecule. These genetic changes are not found in escape mutants selected with other anti-G protein antibodies, even though some of the MAb 63G-resistant viruses are also resistant to most strain-specific anti-G protein antibodies. Thus, anti-0001-0998 © 1992 SGM bodies like 63G may be particularly suited for the selection of frameshift mutants containing insertions or deletions of adenosines in certain areas of the G protein gene. We have now used synthetic peptides to characterize the epitope recognized by MAb 63G, and have evaluated the capacity of these peptides to induce a neutralizing immune response against human RSV.
Methods
Viruses. The Long strain (subgroup A) of human RSV was used as the prototype throughout. The isolation and characterization of mutants R63/1/2/3, R63/2/4/1 and R63/2/4/8, which escape neutralization by MAb 63G, have been reported (Garcia-Barreno et al., 1990) . The viruses were grown in monolayers of actively growing HEp-2 cells and purified from the culture supernatant as described (Garcia-Barreno et al., 1988) .
ELISA. This was done in 96-well microtitre plates coated with purified virus or synthetic peptide (1 ~tg/well) as described (GarciaBarreno et al., 1989) . The bound antibodies were developed using the biotin-streptavidin system and o-phenylenediamine-hydrogen peroxide as recommended by the manufacturer (Amersham).
Synthetic peptides. The peptides indicated in Fig. 1 were synthesized in an Applied Biosystems 430 synthesizer using the solid-phase t-Boc chemistry originally described by Merrifield (1986) . The peptides were cleaved from the resin using PMSF and separated from protective groups and scavengers by Sephadex G-10 chromatography. The peptide deletion set shown in Fig. 3 was synthesized using the multiple solid-phase peptide synthesis technique of Houghten (1985) , as previously described (Akerlind-Stopner et al., 1990) .
Antiserum preparation. Each peptide (2 mg) was coupled to 5 mg of glntaraldehyde-activated keyhole limpet haemocyanin (KLH) for 16 to 18h at room temperature. The peptide-KLH complexes were separated from free peptide by size exclusion chromatography on Sephadex G-50.
Each peptide (2 mg), either free or bound to KLH, was emulsified with an equal volume of complete Freund's adjuvant and used to immunize rabbits (New Zealand white) by multiple dorsal subcutaneous injections. Four weeks later, the rabbits received a second intramuscular dose and 15 days later a third dose of the peptide emulsified in incomplete Freund's adjuvant. The rabbits were bled l week after the third dose and antisera were prepared.
The antisera raised against purified RSV or G protein were prepared in rabbits as described (Palomo et al., 1991) . Each rabbit received three doses of virus (100 ~tg each) or G protein (20 ~tg) subcutaneously, at 3-week intervals. The first dose was mixed with complete Freund's adjuvant and the subsequent doses with incomplete Freund's adjuvant. Rabbits were bled 1 week after administration of the last dose.
Western blotting. Proteins from purified virus were separated by SDS-PAGE (Studier, 1973) and eleetrotransferred to Immobilon paper (Millipore) (Towbin et al., 1979) , which was then cut into strips and incubated with individual antisera. The antigen-antibody complexes were detected by using biotinylated anti-rabbit immunoglobulin, streptavidin-peroxidase and 4-chloro-l-naphthol as recommended by the manufacturer (Amersham).
Neutralization test. Serial dilutions of the antisera (20 ~tl) were mixed with 2 x 103 p.f.u, of Long strain RSV in Dulbecco's medium with 2.5% foetal calf serum (DMEM 2.5). After incubation for 60 min at 37 °C, the virus-antibody mixtures were used to infect monolayers of HEp-2 cells grown in 96-well tissue culture plates. After 2 h at 37 °C, the inoculum was replaced by DMEM 2.5. Plates were incubated for 3 days at 37 °C, fixed with 10~ formaldehyde in PBS and stained with crystal violet. After visual inspection, the serum titre was taken as the highest dilution that inhibited monolayer destruction.
Results

Reactivity of MAb 63G with synthetic peptides
We have reported previously the isolation and characterization of mutants of RSV Long strain which escape neutralization by MAb 63G. These escape mutants contain insertions and deletions of single adenosine residues at the sites indicated in Fig. 1 . These genetic alterations introduce frameshifts in the mutant mRNAs which affect the C-terminal sequence of the G glycoprorein ( Fig. 1) and have important consequences for its antigenicity. Mutants R63/1/2/3 and R63/2/4/8 contain a single adenosine deletion after nucleotides 588 and 623, respectively. The encoded mutant proteins are 25 amino acids shorter than the wild-type protein, the final 81 or 69 amino acids are encoded in the + 1 reading frame, and the proteins have lost the binding sites for many strainspecific MAbs. In contrast, mutant R63/2/4/1 contains two frame-shifts generated by the deletion of an adenosine at position 623 and the insertion of another adenosine at position 648. Thus, the R63/2/4/1 sequence predicts a G protein with seven amino acid changes (205 to 211), but of wild-type length. This protein loses only the binding site for MAb 63G (Garcia-Barreno et al., 1990) .
The above results predict the location of the epitope of MAb 63G to be around amino acids 205 to 211 of the Long strain G protein, replaced in mutant R63/2/4/1. To confirm this location, three overlapping peptides were synthesized: G1 (187 to 200), G2 (196 to 213) and G3 (201 to 218) (Fig. 1) . When tested by ELISA, only peptides G2 and G3 reacted with MAb 63G (Fig. 2) . This result located the epitope of MAb 63G to residues 201 to 213. To confirm this conclusion, a 13-mer G2-G3 (201 to 213) peptide was synthesized (Fig. 1 ) and its reactivity with MAb 63G was confirmed by ELISA (Fig. 2) .
Two other peptides were synthesized as controls. G4 corresponds to amino acids 145 to 160 of the Long strain G protein, outside the tentative site for the epitope of MAb 63G and GIIF contains amino acids 198 to 213 of the mutant R63/1/2/3 G protein, encoded by the +1 reading frame of the G protein mRNA (Fig. 1) . Both the G4 and GIIF peptides failed to react with MAb 63G in the ELISA (Fig. 2) .
To determine the amino acid dependence of the antigenic activity of peptide G2-G3, a set of peptides with single deletions was synthesized. These peptides were then tested by ELISA against MAb 63G (Fig. 3) . The results obtained indicated that deletion of any amino acid between residues 204 and 209 drastically reduced the reactivity with MAb 63G, whereas the deletion of other residues had little or no effect.
Preparation and characterization of antisera raised against the synthetic peptides
The capacity of peptides G1, G2, G3 and G4 to induce a humoral immune response was tested after repeated inoculation of rabbits with peptides free or bound to KLH. All antisera contained antibodies which reacted with the homologous peptide in an ELISA (Fig. 4) . In all cases, the titre of the antisera from rabbits inoculated with the peptides bound to KLH was higher than that obtained with free peptides. Peptides G2 and G3 induced antisera with the lowest and highest titres, respectively.
The capacity of the antipeptide antibodies to recognize the mature G protein was tested by Western blotting (Fig. 5) . All the antisera recognized a band of 80K to 90K which comigrated with the G polypeptide; however, the anti-G2 and -G4--KLH antisera reacted poorly in this assay.
Since the antipeptide antisera reacted with both the homologous peptide and the denatured G molecule, we tested the capacity of these antisera to react with the G protein of the mature virus particle by using an ELISA and a neutralization test. Purified virions of either the Long strain or the mutants resistant to MAb 63G (Fig. 1) (a) KPTKKPTFKTrKK G2-G3 were used to coat E L I S A plates, w h i c h were t h e n tested w i t h the different antisera. T h e E L I S A titre of e a c h a n t i s e r u m w i t h the wild-type virus a n d the escape m u t a n t s is s h o w n in T a b l e 1. O n l y the a n t i -G 1 -K L H a n t i s e r u m c o n t a i n e d a n t i b o d i e s reactive in this assay. T h i s a n t i s e r u m r e c o g n i z e d the L o n g s t r a i n virus a n d the R63/2/4/1 a n d R63/2/4/8 m u t a n t s , b u t d i d n o t react w i t h m u t a n t R63/1/2/3. T h i s result is in a g r e e m e n t w i t h the s e q u e n c e d a t a r e p o r t e d p r e v i o u s l y ( G a r c i a -B a r r e n o et al., 1990), because in mutant R63/1/2/3 all the amino acids after residue 193 are altered, including the sequence present in the G1 peptide (see Fig. 1 ). The neutralizing capacity of the antipeptide antisera was evaluated in a microneutralization test. The results obtained (Table 1) confirmed that, as was found in the ELISA, only the anti-G 1-KLH antiserum had a neutralizing titre comparable to that of antisera raised against either purified G protein or purified Long strain virus. All other antipeptide antisera were negative in this assay.
Discussion
Mapping of the epitope recognized by MAb 63G on the G glycoprotein of human RSV confirms the location predicted from the genetic changes observed in escape mutants selected with MAb 63G. Thus, the ELISA binding of peptides G2 and G3 to MAb 63G correlates with the finding that mutant R63/2/4/1 had lost only this epitope of 19 strain-variable epitopes. This mutant contains two reading frame changes which replace residues 205 to 211 with the amino acids encoded in the + 1 reading frame of the Long strain G mRNA. Peptides with single amino acid deletions identified residues 204 to 209 as essential for the integrity of the epitope recognized by MAb 63G. These results suggest that the binding site of MAb 63G on the G molecule is determined by consecutive amino acids.
It is worth noting that escape mutants selected with MAb 63G contain frameshifts generated by insertions or deletions of single adenosines in runs of six or seven adenosines in the G protein gene (Garcia-Barreno et al., 1990 ). These changes are probably generated by a slippery polymerase that shifts on the RNA template during replication. The sites of the adenosine clusters, surrounding the location of the epitope recognized by MAb 63G, could contribute to the high frequency of isolation of frameshift mutants with MAb 63G. These antigenic and genetic changes may be relevant for the natural history of RSV. Recently, Sullender et al. (1991) have provided evidence that frameshifts introduced by deletions and insertions of adenosines are also found among natural isolates of RSV.
The site deduced for the epitope of MAb 63G places it near the four cysteine residues (amino acids 173, 176, 182 and 186) of the G protein ectodomain. This region of the G molecule has been suggested to include the receptorbinding site (Johnson et al., 1987) . If this prediction is correct, it can be hypothesized that the neutralization mediated by MAb 63G might be related to interference with receptor binding. In this respect, it is relevant that peptide G1 bound to KLH was unique in inducing neutralizing antibodies; however, antibodies directed against peptides G2 and G3, which include the residues of the epitope, failed to neutralize the virus although they did recognize the G protein in Western blotting experiments. These results highlight the difficulties of predicting the biological properties of antibodies, which might depend on the local conformation of epitopes in the mature protein.
